Instem (INS.L) Stock Price
Instem Price
Revenue has compounded at 14.1% per year over the past 15 years to 57.63 M GBP. Earnings per share have declined at 8.5% per year over the last 15 years. Instem's net margin stands at 8.2%, up from 6.5% several years earlier.
Instem stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Instem business model & stock analysis
Frequently asked questions about Instem
The main competitors of Instem PLC in the market include companies such as LabCorp, Medidata Solutions, Oracle Health Sciences, and Parexel International.
Instem PLC is a leading provider of software solutions and services for the life sciences industry. The company primarily operates through its informatics solutions which help organizations streamline their research and development processes. Instem's software products facilitate data management, analysis, and compliance across various stages of the drug discovery and development lifecycle. By offering comprehensive solutions, Instem PLC enables organizations to improve efficiency, enhance decision-making, and accelerate time-to-market for new therapies. With a strong focus on technological innovation and domain expertise, Instem PLC continues to drive advancements in the life sciences industry.
Instem PLC is primarily active in the healthcare and life sciences industry.
Instem PLC is a leading provider of software solutions and services to the global life sciences industry. With over 30 years of experience, Instem has established itself as a trusted partner in providing innovative technology solutions for drug development, regulatory compliance, and research management. Founded in 1987, Instem has grown to become a renowned player in the life sciences space, serving over 500 customers worldwide. The company's comprehensive suite of software solutions spans the entire research lifecycle, enabling organizations to enhance productivity, streamline processes, and drive operational excellence. Instem PLC's dedication to delivering cutting-edge solutions has solidified its position as a key player in the life sciences industry.
Instem PLC has achieved several significant milestones throughout its history. The company has successfully developed and delivered innovative software solutions for the life sciences industry. Instem PLC has been recognized for its contributions to the field, winning numerous industry awards and certifications. The company has formed strategic partnerships and collaborations, expanding its global reach and customer base. Instem PLC has also demonstrated consistent financial growth, with increased revenues and profitability over the years. Additionally, the company has received positive feedback from clients, reinforcing its reputation as a leading provider of software solutions for the life sciences industry.
Instem PLC is primarily present in the United Kingdom, United States, and in several European countries. The company operates globally, providing software solutions and services for the life sciences industry. With its headquarters in the UK, Instem PLC has established a strong presence in key markets, serving clients across North America, Europe, and other parts of the world. As a leading provider of scientific data solutions, Instem PLC offers its innovative products and expertise to support research organizations, pharmaceutical companies, regulatory authorities, and contract research organizations across these regions.
Instem PLC represents a strong set of values and a robust corporate philosophy. The company is committed to delivering innovative software solutions and services to the global life sciences industry. Instem fosters a culture of integrity, excellence, and collaboration to ensure the highest level of customer satisfaction. With a focus on advancing scientific research and improving regulatory compliance, Instem aims to enhance the efficiency and effectiveness of research organizations worldwide. By consistently prioritizing customer success and embracing technologies, Instem PLC is recognized as a leading provider of solutions that drive scientific knowledge and operational excellence in the life sciences domain.
9 analysts currently rate the Instem stock: 8 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Instem share trades at 9.94 EUR (8.30 GBP).
The Instem share (INS.L) is listed on 3 stock exchanges, including: London (INS.L), Frankfurt (54I.F).
Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes. Translation: Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes.
The revenue cannot currently be calculated for Instem.
The profit cannot currently be calculated for Instem.
The P/E ratio cannot be calculated for Instem at the moment.
The P/S cannot be calculated for Instem currently.
The Eulerpool Quality Score for Instem is 6/10.
The ISIN of Instem is GB00B3TQCK30. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Instem is A1C7NS. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Instem is INS.L. The ticker symbol is used to trade Instem shares on the stock exchange.
Instem stock
Instem Peer Group
Instem Ticker
Instem FIGI
All fundamentals and in-depth analysis of Instem
Our stock analysis for Instem stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.